Atman P. Shah, MD1; Elizabeth M. Retzer, MD1; Sandeep Nathan, MD, MSc1; Jonathan D. Paul, MD1; Janet Friant, MSN1; Karin E. Dill, MD2; Joseph L. Thomas, MD3
Atman P. Shah, MD1; Elizabeth M. Ret...
This study conducted a review of all comparative randomized control trials of the pVADS (Impella and TandemHeart) vs IABP for patients undergoing high-risk percutaneous coronary intervention (PCI).
This study conducted a review of all comparative randomized control trials of the pVADS (Impella and TandemHeart) vs IABP for patients undergoing high-risk percutaneous coronary intervention (PCI).